UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX)

CUSIP: 91381U200

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
17,209,280
Total 13F shares
2,582,539
Share change
-251,060
Total reported value
$987,264
Put/Call ratio
30%
Price per share
$0.38
Number of holders
34
Value change
-$333,569
Number of buys
12
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 91381U200?
CUSIP 91381U200 identifies UNBX - UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX) as of Q2 2025

As of 30 Jun 2025, UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,582,539 shares. The largest 10 holders included ARCH Venture Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, RENAISSANCE TECHNOLOGIES LLC, BlackRock, Inc., MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Founders Fund V Management, LLC, and STATE STREET CORP. This page lists 34 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.